Lutonix Av Pas Cl003301
Research payments
$898,587
Through program year 2025, $898,587 in research payments was reported against Lutonix Av Pas Cl003301, across 84 payments.
- Paid by (largest first)
- Bard Peripheral Vascular, Inc.; C. R. Bard, Inc. & Subsidiaries
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $244,114 | 11 |
| 2024 | Research | $288,597 | 23 |
| 2023 | Research | $23,610 | 1 |
| 2022 | Research | $161,061 | 15 |
| 2021 | Research | $43,063 | 11 |
| 2020 | Research | $44,933 | 14 |
| 2019 | Research | $93,209 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Rivero Rochester, NY Named on 5 payments
- Juan Carlos Perez Lozada New Haven, CT Named on 5 payments
- Eric Peden Houston, TX Named on 5 payments
- Mahmood Razavi Orange, CA Named on 4 payments
- Geetha Jeyabalan Pittsburgh, PA Named on 4 payments
- Alexander Yevzlin Ann Arbor, MI Named on 3 payments
- Michael Girard San Diego, CA Named on 3 payments
- Bharat Sachdeva Shreveport, LA Named on 3 payments
- Melhem Sharafuddin Colorado Springs, CO Named on 3 payments
- Amit Dwivedi Louisville, KY Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.